" "
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The ASAP Praises Catheter System which Supports Best Practice Aseptic Technique and Helps Improve Healthcare Worker Safety

Published: Tuesday, October 02, 2012
Last Updated: Tuesday, October 02, 2012
Bookmark and Share
BD NexivaTM Closed IV Catheter System designed to help prevent needlestick injuries and minimise blood exposure.

The Association for Aseptic Practice (ASAP) announced today that it endorses BD Nexiva TM Closed IV Catheter System as a best practice medical device that has been designed to address specific problems in aseptic practice; namely, the risk of catheter-related bloodstream infections (CRBSIs).  This system is the first IV catheter system to be recognised as supporting The ASAP and Aseptic Non-Touch Technique (ANTT®) clinical framework.

The ASAP is committed to improving standards of aseptic technique in clinical practice.  Poor standards of aseptic technique can be a major cause of healthcare-acquired infections (HAIs), such as MRSA and MSSA.  The ASAP oversees the understanding and development of ANTT, a unique, widely recognised and adopted standardised approach to aseptic practice which has been shown to considerably help reduce HCAIs.  BD NexivaTM helps to ensure that best aseptic practice is achieved and clinical procedure is not compromised.

Stephen Rowley, Clinical Director, ANTT UK / USA said, our evaluation identified that “BD Nexiva TM design will help promote asepsis and assists in aseptic technique pre and intra-procedure. The design should also help reduce insertion attempts and improve first-stick success. The blood and needle containment systems were also considered to be innovative ways of protecting health care staff.

Used for peripheral venous access, the all-in-one BD NexivaTM system has BD Instaflash™ technology which is designed to reduce insertion attempts and with its innovative blood-containment system limit healthcare workers’ exposure to blood   This safety-engineered system is also designed to reduce needlestick injury by using passive needle-shielding technology that does not compromise the insertion techniques.

Studies in Europe have estimated that the associated costs of CRBSIs may be hundreds of millions of euros. An important feature incorporated into the BD Nexiva™ Closed IV Catheter System is the BD Q-SyteTM Luer Access Split Septum, which offers a straight and unobstructed fluid path, high flow rates, clear visibility and ease of disinfection.  A split septum needle access system has 64-70% lower CRBSI rates than mechanical halves. By eliminating the complexities of mechanical valves, this split-septum device helps reduce the number of places where bacteria may thrive[iv]. In fact, comparison studies found that patients are three times more likely, on average, to develop a CRBSI with mechanical valves versus a split-septum needle-less access system.

Aseptic practice defines the infection control method and precautions taken during invasive clinical procures to prevent the transfer of micro organisms from the healthcare worker, procedure equipment or the immediate environment to the patient.  It is achieved by ensuring the asepsis of key-parts and key-sites.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BD Diagnostics MRSA Assay Receives FDA Clearance
Company receives FDA clearance to market the BD MAX™ MRSA XT Assay for use on the fully-automated BD MAX™ System.
Tuesday, January 14, 2014
BD Diagnostics Receive FDA Clearance for StaphSR Assay
BD has received FDA clearance to market the BD MAX™ StaphSR Assay for use on the fully-automated BD MAX™ System.
Tuesday, December 03, 2013
BD announces award to NHS Supply Chain Framework Agreement
New award to the national framework agreement for Microbiology generates interest.
Monday, December 10, 2012
Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics
BD Diagnostics convenes experts to address pressing topics for clinical laboratory professionals. Focus will be on the growing role of molecular diagnostics in women’s health, as well as advances in its implementation in the clinical laboratory.
Monday, March 05, 2012
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies
Company announced the expansion of its microbiology portfolio to include new automated instrumentation technologies that will enable the Company to offer innovative total lab automation solutions to hospitals and laboratories worldwide.
Thursday, February 16, 2012
Scientific News
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Head Injury Patients Develop Brain Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
New Way to Identify Brain Tumor Aggressiveness
Looking at a brain tumor’s epigenetic signature may help guide therapy.
OncoCyte, The Wistar Institute Enter Global Licensing Agreement
Exclusive rights to commercialize biomarker assay follows years of positive collaboration on lung cancer diagnostic test.
Easier Diagnosis for Fungal Infection of the Lungs
A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner and more effectively.
Antibiotic Susceptibility Testing
A team of biologists and biomedical researchers at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours, an advance that could slow the appearance of drug resistance and allow doctors to more rapidly identify the appropriate treatment for patients with life threatening bacterial infections.
Mitochondrial Troublemakers Unmasked in Lupus
Drivers of autoimmune disease inflammation discovered in the traps of pathogen-capturing white blood cells.
DNA Analysis in the Fast Lane
Rice bioengineers' method should lead to better database of thermal behaviors.
‘Simple Rules’ Calculate Ovarian Cancer Risk
Scientists have formulated a system that uses ultrasound images to accurately work out the likelihood of an ovarian growth being cancerous.
Finding the Needle in a Microbial Haystack
After developing a novel investigational technology called PathoChip that can rapidly identify elusive microorganisms, a team of Penn Medicine researchers recently succeeded for the first time in identifying a pathogen in a patient sample, demonstrating the proof of principle that this technology can be used to identify pathogens in human disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!